Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Adrenocortical carcinoma
Stage/Subtype:  stage III adrenocortical carcinoma
Country:  U.S.A.
Trial Type:  Treatment
Results 1-6 of 6 for your search:
Start Over
Hyperthermic Intraperitoneal Cisplatin after Surgery in Treating Patients with Adrenocortical Cancer That Has Spread throughout the Abdomen
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 13-C-0114, NCI-2013-01590, P131214, NCT01833832
Pembrolizumab in Treating Patients with Adrenocortical Cancer That Cannot Be Removed by Surgery or is Metastatic
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15-286, NCI-2016-00224, NCT02673333
Nivolumab in Treating Patients with Metastatic Adrenocortical Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NU 15E01, STU00202153, NCI-2016-00194
Iodine I 131 Monoclonal Antibody 8H9 in Treating Patients with Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 1 and over
Trial IDs: 09-090, NCI-2010-01242, NCT01099644
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: EMR 100070-001, NCI-2013-02214, 2013-002834-19, NCT01772004
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ATR-101-001, NCI-2013-02392, NCT01898715
Start Over